Improvement of the evaluation method for teratogenicity using zebrafish embryos.

The zebrafish has been considered as a suitable animal model for drug discovery, especially for evaluation of the teratogenicity, due to their small size, rapid development, transparency, and developmental similarities to mammalian development. These features of zebrafish make it possible to maintain them in culture plates, evaluate the teratogenicity in short term, conduct morphological assessment of each organ without any autopsy operation. The purpose of the present study was to improve an evaluation method for the teratogenicity of test compounds with high throughput ability and prediction rateusing zebrafish embryos. In this study, we established a modified evaluation method as using non-dechorionated embryos and observation a limited number of parameters without grading. Zebrafish embryos were exposed to test compounds from 5-6 to 144 hr post-fertilization, (hpf) corresponding to the organogenesis period. Morphological changes or functional abnormalities induced by test compound treatments were assessed and scored at 11 endpoints, and the potential of teratogenicity was judged based on the score. As a validation assay of the system, the potentials of 59 known teratogenic or non-teratogenic test compounds were evaluated using the present standard zebrafish assay, and the teratogenicity was correctly predicted in 90% (53/59) of all compounds with low false negative and false positive rates. These results indicated that the evaluation method using zebrafish for the teratogenicity we have improved was a valuable tool for early stage screening in drug discovery.

[1]  L. Zon,et al.  In vivo drug discovery in the zebrafish , 2005, Nature Reviews Drug Discovery.

[2]  T. Braunbeck,et al.  Dechorionation as a tool to improve the fish embryo toxicity test (FET) with the zebrafish (Danio rerio). , 2011, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[3]  H. Nau,et al.  Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. , 1996, Teratogenesis, carcinogenesis, and mutagenesis.

[4]  C. Kimmel,et al.  Stages of embryonic development of the zebrafish , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[5]  H Raabe,et al.  Prevalidation of the Embryonic Stem Cell Test (EST)-A New In Vitro Embryotoxicity Test. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[6]  A. Ornoy.  Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. , 2006, Reproductive toxicology.

[7]  J. Heintzman,et al.  NSAID prescribing precautions. , 2009, American family physician.

[8]  J. Finn,et al.  Effects of propranolol on heart rate and development in Japanese medaka (Oryzias latipes) and zebrafish (Danio rerio). , 2012, Aquatic toxicology.

[9]  Wim De Coen,et al.  Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. , 2009, Reproductive toxicology.

[10]  H. Tuchmann-duplessis,et al.  Effects of prenatal administration of acetylsalicylic acid in rats. , 1975, Toxicology.

[11]  G. Chamorro-Cevallos,et al.  Reduction of all-trans-retinoic acid-induced teratogenesis in the rat by glycine administration. , 2006, Birth defects research. Part A, Clinical and molecular teratology.

[12]  R. Nagel.  DarT: The embryo test with the Zebrafish Danio rerio--a general model in ecotoxicology and toxicology. , 2002, ALTEX.

[13]  J. Connor,et al.  The metabolism of ribavirin in erythrocytes and nucleated cells. , 1990, The International journal of biochemistry.

[14]  G. Koren,et al.  Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. , 2002, American journal of obstetrics and gynecology.

[15]  N. Tanaka,et al.  Marked elevation of erythrocyte ribavirin levels in interferon and ribavirin-induced anemia. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  O. Flint,et al.  In vitro tests for teratogens: desirable endpoints, test batteries and current status of the micromass teratogen test. , 1993, Reproductive toxicology.

[17]  F. Gao,et al.  Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. , 2003, Birth defects research. Part B, Developmental and reproductive toxicology.

[18]  A. Walsh,et al.  Inhibition of synaptosomal [3H]noradrenaline uptake by beta-adrenoceptor blocking drugs: influence of lipophilicity. , 1984, European journal of pharmacology.

[19]  A. K. Peters,et al.  Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  A. Piersma,et al.  Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles. , 2011, Toxicology and applied pharmacology.

[21]  S. Shapiro,et al.  PERINATAL MORTALITY AND BIRTH-WEIGHT IN RELATION TO ASPIRIN TAKEN DURING PREGNANCY , 1976, The Lancet.

[22]  R. Blust,et al.  Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. , 2012, Reproductive toxicology.

[23]  T. Seki,et al.  Improvement of the embryonic stem cell test endpoint analysis by use of field potential detection. , 2010, The Journal of toxicological sciences.

[24]  Julieta M. Panzica-Kelly,et al.  Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. , 2010, Birth defects research. Part B, Developmental and reproductive toxicology.

[25]  Zhiyuan Gong,et al.  Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models , 2011, Expert opinion on drug metabolism & toxicology.

[26]  L. Zon,et al.  Zebrafish: a model system for the study of human disease. , 2000, Current opinion in genetics & development.

[27]  T. Knudsen,et al.  Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice. , 1980, Toxicology and applied pharmacology.

[28]  Y. Siddiqui,et al.  Effect of beta-adrenergic agents on intracellular potential of rabbit ciliary epithelium. , 1998, Current eye research.

[29]  Toshihiko Ogura,et al.  Identification of a Primary Target of Thalidomide Teratogenicity , 2010, Science.

[30]  Nobuyuki Horie,et al.  Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  Richard E Peterson,et al.  Zebrafish as a model vertebrate for investigating chemical toxicity. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  Liwei Sun,et al.  Toxicity and enantiospecific differences of two β‐blockers, propranolol and metoprolol, in the embryos and larvae of zebrafish (Danio rerio) , 2014, Environmental toxicology.

[33]  T. Braunbeck,et al.  DMSO modifies the permeability of the zebrafish (Danio rerio) chorion-implications for the fish embryo test (FET). , 2013, Aquatic toxicology.

[34]  Julieta M. Panzica-Kelly,et al.  Morphological score assignment guidelines for the dechorionated zebrafish teratogenicity assay. , 2010, Birth defects research. Part B, Developmental and reproductive toxicology.

[35]  Y. Matsuzaki,et al.  Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[36]  E. M. Johnson.  Developmental toxicity and safety evaluations of ribavirin. , 1990 .

[37]  P. Brown-Woodman,et al.  A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing. , 1997, The International journal of developmental biology.